Hisashi Shirakawa Selected Research

neurotropin

7/2018

Neurotropin inhibits neuronal activity through potentiation of sustained Kv currents in primary cultured DRG neurons.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hisashi Shirakawa Research Topics

Disease

7	Hyperalgesia 01/2017 - 06/2008
7	Pain (Aches) 01/2017 - 12/2008
6	Inflammation (Inflammations) 01/2022 - 03/2012
6	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 07/2012
5	Ischemia 01/2021 - 11/2004
5	Brain Injuries (Brain Injury) 01/2021 - 09/2010
5	Neuralgia (Stump Neuralgia) 07/2018 - 12/2008
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 03/2015
4	Multiple Sclerosis 01/2022 - 01/2018
4	Hypersensitivity (Allergy) 11/2018 - 07/2012
4	Cold Hypersensitivity 01/2018 - 07/2012
4	Cystitis 02/2017 - 01/2013
3	Cognitive Dysfunction 01/2019 - 01/2018
2	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 01/2021
2	Cerebral Hemorrhage 01/2020 - 01/2012
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2019 - 10/2017
2	Hypoxia (Hypoxemia) 01/2018 - 03/2016
2	Wounds and Injuries (Trauma) 01/2017 - 04/2006
2	Gliosis 07/2013 - 09/2010
2	Astrocytoma (Pilocytic Astrocytoma) 01/2012 - 09/2008
2	Fibrosis (Cirrhosis) 11/2009 - 10/2008
2	Heart Failure 11/2009 - 10/2008
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022
1	Tardive Dyskinesia 01/2021
1	Hyperkinesis 01/2021
1	Dyskinesias (Dyskinesia) 01/2021
1	Paralysis (Palsy) 01/2020
1	Body Weight (Weight, Body) 12/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Gout 01/2017
1	Postoperative Pain 01/2017
1	Paresthesia (Dysesthesia) 03/2016
1	Insulin Resistance 01/2016
1	Diabetes Mellitus 01/2016
1	Infarction (Infarctions) 11/2015
1	Mood Disorders (Mood Disorder) 04/2015

Drug/Important Bio-Agent (IBA)

5	AnkyrinsIBA 01/2018 - 01/2016
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017 - 07/2012
4	CytokinesIBA 01/2021 - 05/2012
4	Pharmaceutical PreparationsIBA 01/2020 - 01/2013
4	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2017 - 01/2013
4	Thrombin FDA Link 07/2013 - 09/2008
3	Analgesics (Analgesic Drugs)IBA 07/2018 - 01/2014
3	PlatinumIBA 01/2017 - 07/2012
3	CarrageenanIBA 03/2015 - 12/2008
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2022 - 12/2019
2	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2016
2	ChemokinesIBA 01/2020 - 01/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2018 - 03/2015
2	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 01/2018 - 07/2012
2	Oxygen (Dioxygen)IBA 10/2017 - 11/2004
2	OxalatesIBA 01/2016 - 07/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2015 - 07/2012
2	Amitriptyline (Elavil)FDA LinkGeneric 01/2014 - 01/2014
2	Tramadol (K315)FDA LinkGeneric 01/2014 - 01/2014
2	Morphine (MS Contin)FDA LinkGeneric 01/2014 - 01/2014
2	Messenger RNA (mRNA)IBA 03/2012 - 10/2008
2	Glucose (Dextrose)FDA LinkGeneric 10/2008 - 11/2004
2	N-Methylaspartate (NMDA)IBA 03/2006 - 11/2004
1	Dinoprostone (PGE2)FDA Link 01/2022
1	OxadiazolesIBA 01/2022
1	5-HT2C Serotonin ReceptorIBA 01/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2022
1	Dopamine D2 Receptor AntagonistsIBA 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021
1	Biological ProductsIBA 12/2020
1	LipidsIBA 12/2020
1	3-phenylcoumarinIBA 12/2020
1	Therapeutic UsesIBA 01/2020
1	N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA 01/2020
1	Freund's AdjuvantIBA 12/2019
1	CuprizoneIBA 12/2019
1	myelin oligodendrocyte glycoprotein (35-55)IBA 12/2019
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2019
1	pexidartinibIBA 01/2019
1	Macrophage Colony-Stimulating FactorIBA 01/2019
1	QuinpiroleIBA 01/2019
1	neurotropinIBA 07/2018
1	Vasodilator Agents (Vasodilators)IBA 01/2018
1	Ion Channels (Ion Channel)IBA 01/2018
1	Tadalafil (Cialis)FDA Link 01/2018
1	Chemokine CXCL2IBA 01/2018
1	2,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA 01/2018
1	CationsIBA 01/2018
1	Clodronic Acid (Clodronate)IBA 01/2017
1	Colchicine FDA LinkGeneric 01/2017
1	Liposomes (Liposome)IBA 01/2017
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 03/2016
1	Proline (L-Proline)FDA Link 03/2016
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2016
1	Cholecalciferol (Vitamin D3)FDA Link 01/2016
1	Drug CombinationsIBA 01/2016
1	Vitamin D FDA LinkGeneric 01/2016
1	capsazepineIBA 11/2015
1	Serotonin (5 Hydroxytryptamine)IBA 04/2015

Therapy/Procedure

6	Ligation 11/2018 - 12/2008
4	Intravesical Administration 02/2017 - 01/2013
3	Therapeutics 01/2018 - 10/2008
1	Intravenous Injections 01/2017